The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Smiths Medical president Srini Seshadri is expected to step down, and Zimmer (NYSE:ZMH) executive Jeff McCaulley will step into the top office.
There was no reason given for Seshadri’s departure. He joined the company in 2006 and helped navigate some tough times when it was under-performing, Smiths said.
keys: angiodynamics, cfo, alan panzer
Albany, N.Y.-based AngioDynamics (NSDQ:ANGO) said Alan Panzer, its general manager of U.S. sales, will no longer be with the company as of July 31, 2013.
AngioDynamics loses EVP & CFO
Albany, N.Y.-based AngioDynamics’ executive vice president & CFO Joseph Gersuk retired from the company, effective January 31, 2013.
ProUroCare Medical (OTC:PUMD) won the FDA’s okay for its flagship ProUroScan system, a diagnostic imaging device for detecting irregularities in the prostate.
The Minneapolis, Minn.-based company plans this year to launch ProUroScan at "a limited number of top U.S. medical centers in key metropolitan markets," according to a press release.
iRobot Corp. (NSDQ: IRBT), famous for their Roomba automated cleaning robots, invested $6 million and launched an extended partnership with InTouch Health, which develops telemedicine systems for providing remote health care.
The venture builds on an existing relationship that the companies announced last summer, under which the companies engaged in a development and licensing agreement.
Conceptus (NSDQ:CPTS) swapped out $50 million worth of 2.25% senior notes due 2027 from a select group of holders, exchanging them for 5% notes due 2031, regulatory filings show.
The principal amount on the new notes was an even swap for the originals, which was determined in individual negotiations between Conceptus and the holders.
Kensey Nash Corp. (NSDQ:KNSY) landed a small business innovation research grant from the National Institutes of Health to investigate the use of surgical mesh for tendon repair procedures.
The two-year, $1.9 million grant will allow the Exton, Pa.-based regenerative medicine developer to investigate the ability of its bioadhesive mesh to improve standard sutured tendon repair.
Semprus BioSciences Corp. won a $1 million grant to develop orthopedic devices resistant to biofilm formation for the U.S. Army’s Telemedicine & Advanced Technology Research Center.
Biofilms are the foundation for the most bacterial complications associated with implanted medical devices, according to a Semprus press release.
